Healthcare Industry News: kidney disease
News Release - October 11, 2007
Sorin Group Announces the Appointment of Fred Hrkac as President Cardiac Rhythm Management Business UnitMILAN, Italy--(HSMN NewsFeed)--The Sorin Group (MIL:SRN) announced today that Fred Hrkac has been appointed President, Cardiac Rhythm Management (CRM) Business Unit, reporting to Andre-Michel Ballester, recently appointed CEO of the Sorin Group, the largest European cardiovascular company and world leader in medical technologies for cardiac surgery.
Since 2005, Fred Hrkac has been Vice President, Global Sales and Marketing, of the Sorin Group CRM Business Unit.
Fred Hrkac, a Canadian/ Croatian national brings with him thorough international management experience in Sales and Marketing.
He spent most of his career within Johnson and Johnson in various positions in Sales and Marketing. In his last position, he was Vice President Worldwide Sales & Marketing for Biosense Webster, a global leader in Electrophysiology.
He has good knowledge of Europe where he has been working for 15 years living in five different countries, as well as in the USA and Canada.
He was raised in Canada and graduated from Wilfrid Laurier University, Waterloo, Ontario (Canada) with a Honors Bachelor Business Administration degree.
"I am very proud and honoured to become President of this Business Unit, an emerging player in the CRM industry. In my new role I will continue to make it possible for Sorin Group to expand its presence worldwide thanks to our talented employees and innovative solutions that we bring to patients and physicians worldwide."
About the Sorin Group
The Sorin Group (Bloomberg: SRN.IM; Reuters: SORN.MI), a world leader in the development of medical technologies for cardiac surgery, offers innovative therapies for cardiac rhythm dysfunctions, interventional cardiology and the treatment of chronic kidney diseases. The Sorin Group includes these brands: Dideco, CarboMedics, COBE Cardiovascular, Stockert, Mitroflow, ELA Medical, Sorin Biomedica, Bellco and Bellco-Soludia. At the Sorin Group 4,500 employees work to serve over 5,000 public and private treatment centers in more than 80 countries throughout the world. For more information, please visit: www.sorin.com
Source: Sorin Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.